Table 2-.
Summary of ADNI dataset, the number of observations in each follow-up visit and the features extracted from each modality
| Source* | Number of observations | Features | |||||
|---|---|---|---|---|---|---|---|
| T1 | T6 | T12 | T24 | T36 | T48 | ||
| MRI | 1465 | 1333 | 1191 | 987 | 617 | 451 | Ventricular volume, Hippocampus volume, Whole Brain volume, Entorhinal Cortical thickness, Fusiform, Middle temporal gyrus, and intracranial volume (ICV) |
| PET | 1127 | 1009 | 892 | 714 | 429 | 335 | FDG, Pittsburgh Compound-B (PIB), AV45 |
| Cognitive Test ** | 1525 | 1357 | 1207 | 997 | 627 | 456 | Rey Auditory Verbal Learning Test (RAVLT Immediate, RAVLT Learning, RAVLT Forgetting, RAVLT Perc Forgetting), Functional Activities Questionnaires (FAQ), Everyday Cognition (Ecog) scales: (EcogPtMem, EcogPtLang, EcogPtVisspat, EcogPtPlan, EcogPtOrgan, EcogPtDivatt, EcogPtTotal,EcogSPMem, EcogSPLang, EcogSPVisspat, EcogSPPlan, EcogSPOrgan, EcogSPDivatt, and EcogSPTotal) |
| CSF | 1014 | 914 | 806 | 662 | 404 | 305 | Amyloid Beta (ABETA), Phosphorylated Tau Protein (PTAU), and Total Tau Protein (TAU) |
| Risk factors | 1737 | Age, gender, years of education, and APOE4 | |||||
In this table MRI refers to Magnetic Resonance Imaging, PET refers to Positron Emission Tomography, COG refers to Cognitive assessment tests and CSF refers to Cerebrospinal Fluid test.
The Mini-Mental State Examination (MMSE) and Clinical Dementia Rating Sum of Boxes (CDRSB) scores (since initially used for labelling subjects) and Alzheimer’s Disease Assessment Score (ADAS11, ADAS13) and the Montreal Cognitive Assessment (MoCA) (since highly correlated with MMSE) were excluded from the feature set in the training and testing phases of the proposed prediction model.